Latest Research News from the Foundation for Women's Cancer and Society of Gynecologic Oncology

Article

An update from the Foundation for Women's Cancer and Society of Gynecologic Oncology

Hear from Dr. Anil Sood, Foundation for Women's Cancer Research Chairman, and Carol Brown, 2014 Society of Gynecologic Oncology Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women's Cancer. (https://www.youtube.com/watch?v=KKB63TGlOcQ&feature=youtu.be)

Recent Videos
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content
Photo of someone in a white lab coat writing on a clipboard with a stethoscope on it.

Toxicity May Be Underreported in Phase 3 Oncology Trials

Bridget Hoyt
March 12th 2025
Article

A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry sponsored.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Anatomical rendering of the gastrointestinal tract with the colon highlighted in yellow

Panitumumab Combo Elicits Response in mCRC Subset

Bridget Hoyt
March 11th 2025
Article

Panitumumab plus ipilimumab and nivolumab signaled complete or partial response in 18 patients with KRAS/NRAS/BRAF wild-type MSS mCRC at the 12-week mark.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Microscope image of multiple myeloma

Older Patients with Lenalidomide-Refractory MM May Face Treatment Gaps

Roman Fabbricatore
March 10th 2025
Article

Real-world data show that older adults with lenalidomide-refractory MM have poor survival outcomes after 1 to 3 lines of therapy.

Image of red blood cells

Rusfertide Plus SOC Reaches Response End Point in Phlebotomy-Dependent PV

Chris Ryan
March 9th 2025
Article

Clinical response rates were higher in patients with phlebotomy-dependent polycythemia vera who received rusfertide than in those who received placebo.